The GDL Fund Q1 2025 Commentary

2025-06-02 10:50:00 ET

Summary

• The GDL Fund targets absolute returns via merger arbitrage and special situations, aiming for positive performance regardless of market direction.
• The fund currently trades at a 20.5% discount to NAV, offering potential value for investors seeking exposure to M&A-driven strategies.
• Recent M&A activity has rebounded, with robust deal flow and private equity dry powder supporting future opportunities despite ongoing regulatory scrutiny.
• Key holdings include Intra-Cellular Therapies and Patterson Companies, with several deals expected to close soon, supporting the fund's pipeline and return prospects.

INVESTMENT OBJECTIVE

Read the full article on Seeking Alpha

For further details see: